Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes
Conditions: Type 2 Diabetes (Adult Onset) Interventions: Drug: Tirzepatide; Drug: Pioglitazone; Drug: Sitagliptin; Drug: Metformin HCI XR Sponsors: The University of Texas Health Science Center at San Antonio; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials
Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Relative to Originator
Conditions: Healthy Subjects Interventions: Drug: Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Test product; Drug: Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Reference product Sponsors: Bio-innova Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Sitagliptin and Metformin Hydrochloride Tablets 50 mg/1000 mg Relative to Originator
Conditions: Healthy Subjects Interventions: Drug: Sitagliptin and Metformin Hydrochloride Tablets Test product; Drug: Sitagliptin and Metformin Hydrochloride Tablets Reference product Sponsors: Bio-innova Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
A Clinical Trial to Evaluate the Food Effect on Pharmacokinetic Profiles and Safety of CKD-379
Conditions: Type 2 Diabetes Mellitus Interventions: Drug: CKD-379(Empagliflozin+sitagliptin+metformin) Test drug; Drug: CKD-379(Empagliflozin+sitagliptin+metformin) Reference drug Sponsors: Chong Kun Dang Pharmaceutical Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials
To Compare the Safety and Efficacy of Dapagliflozin Plus Metformin Versus Sitagliptin Plus Metformin for Treatment of Diabetes in Patients With Compensated and Stable Decompensated Cirrhosis
Conditions: Compensated Cirrhosis; Decompensated Cirrhosis Interventions: Drug: Metformin; Drug: Sitagliptin; Drug: Dapagliflozin Sponsors: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials
Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.
Conditions: Bioequivalence; Diabetes Mellitus, Type 2 Interventions: Drug: Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet Sponsors: Galenicum Health Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials
Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.
Conditions: Bioequivalence; Diabetes Mellitus, Type 2 Interventions: Drug: Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet Sponsors: Galenicum Health Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials
Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.
Conditions: Bioequivalence; Diabetes Mellitus, Type 2 Interventions: Drug: Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet Sponsors: Galenicum Health Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials
Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.
Conditions: Bioequivalence; Diabetes Mellitus, Type 2 Interventions: Drug: Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet Sponsors: Galenicum Health Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials
Polypill Versus Metformin in New Onset Type 2 Diabetes
Condition: Type 2 Diabetes Interventions: Drug: GMRx4 polypill - sitagliptin, dapagliflozin, metformin; Drug: Metformin Sponsors: George Medicines PTY Limited; MRCF Pty Ltd; The George Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2023 Category: Research Source Type: clinical trials
